Health Related Quality of Life of Youth and Young Adults With Haemophilia A

Summary

Research question: Whether there are the changes in quality of life in patients with haemophilia A after switching from SHL FVIII prophylaxis to efmoroctocog alfa prophylaxis? A 12-month prospective open-label, single-arm multicentre study. Evaluation of parameters will be carried out on the backdrop of patient treatment in the settings of routine medical practice. No medical examinations/ procedures/ treatment(s) on the top of regular medical practice are planned, except fixed time of examinations.

Timeline

Start

2021-04-15

Primary completion

2023-02-20

Completion

2023-02-20

Drugs

Indications